AbbVie Inc. Files 8-K Report

TL;DR

AbbVie filed a routine 8-K, no major news.

AI Summary

On January 30, 2025, AbbVie Inc. filed an 8-K report detailing "Other Events." The filing does not contain specific financial transactions or material events beyond routine reporting requirements, indicating no significant new developments at this time.

Why It Matters

This filing serves as a routine update for investors, confirming no major new events or disclosures from AbbVie Inc. as of January 30, 2025.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report for 'Other Events' and does not disclose any new material risks or significant financial changes.

Key Players & Entities

• AbbVie Inc. (company) — Filer of the 8-K report
• January 30, 2025 (date) — Date of the earliest event reported
• 001-35565 (other) — SEC File Number for AbbVie Inc.

FAQ

From the Filing

0001104659-25-009673.txt : 20250205 0001104659-25-009673.hdr.sgml : 20250205 20250205161517 ACCESSION NUMBER: 0001104659-25-009673 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250130 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 25593475 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 tm255474d1_8k.htm FORM 8-K false 0001551152 Common Stock, $0.01 Par Value ABBV 0001551152 2025-01-30 2025-01-30 0001551152 us-gaap:CommonStockMember exch:XNYS 2025-01-30 2025-01-30 0001551152 exch:XCHI us-gaap:CommonStockMember 2025-01-30 2025-01-30 0001551152 abbv:SeniorNotes0.750Percentdue2027Member exch:XNYS 2025-01-30 2025-01-30 0001551152 abbv:SeniorNotes2.125Percentdue2028Member exch:XNYS 2025-01-30 2025-01-30 0001551152 abbv:SeniorNotes2.625Percentdue2028Member exch:XNYS 2025-01-30 2025-01-30 0001551152 abbv:SeniorNotes2.125Percentdue2029Member exch:XNYS 2025-01-30 2025-01-30 0001551152 abbv:SeniorNotes1.250Percentdue2031Member exch:XNYS 2025-01-30 2025-01-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 30, 2025   ABBVIE INC. (Exact name of registrant as specified in its charter)   Delaware   001-35565   32-0375147 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) ________________________________________________________________      1 North Waukegan Road   North Chicago , Illinois 60064-6400   (Address of principal executive offices)(Zip Code)    Registrant’s telephone number, including area code: ( 847 ) 932-7900   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange Chicago Stock Exchange 0.750% Senior Notes due 2027   ABBV27   New York Stock Exchange 2.125% Senior Notes due 2028   ABBV28   New York Stock Exchange 2.625% Senior Notes due 2028   ABBV28B   New York Stock Exchange 2.125% Senior Notes due 2029   ABBV29   New York Stock Exchange 1.250% Senior Notes due 2031   ABBV31   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ¨   If an emerging growth company, indicate by check